Mycoverse
Key Facts
| Invested since | 2026 |
| Based in | International |
About the company
Mycoverse is a Danish biosolutions company developing fungal-based biological crop protection solutions. A spin-out from the Technical University of Denmark (DTU), Mycoverse uses an AI-driven discovery platform and advanced fungal production technology to develop biocontrol solutions that can replace chemical pesticides. The company’s platform is designed to support scalable, data-driven solutions across multiple crops, with an initial focus on potato late blight and future applications including grapevine. Mycoverse has previously been supported by BioInnovation Institute with € 1.9 million, bringing Mycoverse’s total fundraising up to € 4.3 million.
Do you want to
know more about this company?
Mycoverse in the news
More startups from Life Sciences
Exit
650 million people suffer from mental illness like depression, anxiety or burnout worldwide. Even in developed countries there is a huge treatment gap: 50% do not get treated. Selfapy offers …
to Selfapy
Numaferm developed a platform technology for fast, scalable and cost-efficient production of peptides and proteins, with a focus on pepteins (PEPTides & protEINS) in the range of 30-500 amino acids. …
to NUMAFERM
ActiTrexx GmbH is a spin-off from the University Medical Center Mainz and was founded in 2020. The company develops ATreg, a cell therapy based on activated regulatory T cells that …
to ActiTrexx
PreComb Therapeutics AG is a privately held Swiss biotech company founded in 2018 by Jens M. Kelm, Peter Steiner and Olivier Mauti with the aim of developing technologies that bring …
to PreComb
Development of enzymatic biomanufacturing processes for the production of functional ingredients for nutrition and personal care
to Primogene
AudioCure Pharma is an innovative clinical-stage pharmaceutical company focused on developing treatments for audiological and neurological disorders with a high unmet medical need. Our small molecules have shown Proof-of-Principle in …
to AudioCure
mo:re has developed a groundbreaking lab platform, combining automation and software for planning, executing, and analysis of cell culture studies. The user-friendly platform aims to simplify cell culture, making organoids …
to mo:re
mediaire develops AI-powered diagnostic solutions for MRI imaging, focusing on the seamless integration of AI into clinical workflows to enhance radiologists’ efficiency and diagnostic accuracy. The company’s AI solutions, including …
to mediaire
Exit
The core competency of AQ Implants GmbH is the endoprosthetic reconstruction of severe and complex defects and anomalies. With the development of innovative implant systems AQ Implants GmbH provides surgeons …
to AQ Implants
Treatment of sustainable plaque in coronary arteries through our proprietary catheter based device.
to Cryotherapeutics
HBOX Therapies has developed a technology that facilitates lung-protective treatment of respiratory patients, the patented platform technology HBOX (Hyperbaric Blood Oxygenation). The management team of HBOX Therapies consists of the …
to HBOX Therapies
Alentis Therapeutics discovers and develops novel medications to treat advanced liver diseases, such as liver fibrosis, cirrhosis and liver cancer (hepatocellular carcinoma, HCC). Alentis has in-licensed platform technologies and monoclonal …
to Alentis